Parkinson's Disease Trial, Recruiting NCT06519279 Sponsor: Tel-Aviv Sourasky Medical Center Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06519279
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with idiopathic Parkinson's disease (a specific type of Parkinson's disease with no known cause) by a neurologist, following recognised medical guidelines.
  • People who are able to walk at least 10 metres on their own, without using a walking aid.
  • People who do not have a Deep Brain Stimulator implanted.
  • People whose Parkinson's disease medication has been stable for at least 4 weeks before joining the study, and is not expected to change during the study.
  • For people with "freezing of gait" (episodes where walking suddenly stops): people who score 1 or higher on a specific freezing of gait questionnaire called the NFOG-Q.

Who may not be able to join:

  • People who, within the 3 months before joining, have experienced a heart attack, unstable chest pain requiring hospitalisation, stroke, heart bypass surgery, a procedure to open blocked heart arteries, implantation of a certain type of heart device, active cancer treatment, severe uncontrolled heart failure, acute psychosis or major mental health conditions, ongoing substance misuse, or another neurological or bone/joint condition that significantly affects the way they walk.
  • People who are not willing to temporarily delay taking their morning Parkinson's disease medication on study days.
  • People who are pregnant (confirm with trial site, as the source criteria appear incomplete).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +972546670256

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 October 2024
Est. completion
1 December 2025

Where this trial is recruiting

🇮🇱 Israel

Primary endpoints

Validate the newly-developed ClinRO

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov